"10.1371_journal.pone.0017736","plos one","2011-03-09T00:00:00Z","Kathryn M Schultz; Ghazal Banisadr; Ruben O Lastra; Tammy McGuire; John A Kessler; Richard J Miller; Thomas J McGarry","Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America; Department of Cell and Molecular Biology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America; Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America","Conceived and designed the experiments: TJM RJM. Performed the experiments: KMS ROL GB TM. Analyzed the data: TJM KMS ROL GB. Contributed reagents/materials/analysis tools: TJM JAK RJM. Wrote the paper: TJM.","The authors have read the journal's policy and have the following conflicts: TJM is an inventor for the patent \"Geminin Gene and Protein\" (US Patent #6,548,290) that describes manipulating the Geminin level in cells to treat neurodegenerative diseases. The Assignee for this patent is the President and Fellows of Harvard University. TJM's status as an inventor does not alter our adherence to all PLoS guidelines concerning the sharing of data and materials as outlined in the guidelines for authors.","2011","03","Kathryn M Schultz","KMS",7,TRUE,2,4,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
